Anant Mandawat, MD

Background

Anant Mandawat, MD, serves as the director of Cardio-Oncology at Winship Cancer Institute of Emory University, and holds joint appointments as associate professor in the Department of Hematology and Medical Oncology and in the Division of Cardiology of the Department of Internal Medicine at Emory University School of Medicine. In addition, he co-leads Emory’s multidisciplinary Cardiac Tumor Program which assess and treats masses in the heart.

A cardio-oncologist, Dr. Mandawat is an expert in the early detection, prevention, and treatment of cardiac diseases in patients with cancer. He specializes in cutting-edge techniques to detect cardiac disease early and prevent complications that may result before, during, or after cancer treatment. He has a clinical interest in long-term cardiac risk assessment and follow-up in cancer survivors. He has received advanced training with a specialized fellowship in cardiovascular imaging. He is board-certified in Internal Medicine and Cardiovascular Disease, and has additional board certifications in Echocardiography, and Nuclear Cardiology.

Dr. Mandawat graduated with a medical degree with honors from Yale School of Medicine in New Haven, Connecticut. He completed his internal medicine residency at Massachusetts General Hospital/Harvard Medical School in Boston, Massachusetts. He then completed his fellowship in cardiology at Duke University Medical Center in Durham, North Carolina where he focused on cardio-oncology and advanced cardiovascular imaging.

Titles & Roles

• Associate Professor, Department of Hematology and Medical Oncology

  Emory University School of Medicine
• Associate Professor, Division of Cardiology, Department of Medicine

  Emory University School of Medicine
• Director, Cardio-Oncology Program

  Winship Cancer Institute of Emory University

Education & Training

Education

• Fellowship, Cardiovascular Disease, 2018

  Duke University Hospital
• Residency, Internal Medicine, 2015

  Massachusets General Hospital
• Medical Education, MD, 2012

  Yale University School of Medicine

Board Certifications

• Cardiovascular Disease

  American Board of Internal Medicine, 2018
• Internal Medicine

  American Board of Internal Medicine, 2015

Professional Memberships

Dr. Mandawat holds professional membership in the American College of Cardiology (ACC) and serves on the ACC's Cardiovascular Management Leadership Council.

Research

Dr. Mandawat's research focuses on cardiac outcomes of patients with cancer. He is a leader in cardiovascular toxicity from prostate cancer treatments. He co-leads the Cardio-Oncology PROstate Cancer (CO-PRO) biobank, a prospective translational biobank using immunomics, genomics, and proteomics to better understand mechanisms and risk stratification of cardiovascular toxicity from androgen deprivation therapy.

Publications

Dr. Mandawat has authored numerous peer-reviewed publications and his work has been presented at multiple national meetings. He serves as a manuscript reviewer for cardiology and oncology publications including the Journal of the American College of Cardiology (JACC), JACC Heart Failure, JACC CardioOncology, Cancer, and JCO Oncology Practice. He places a strong emphasis on patient communication and patient-centered care and has served as a contributing editor for Harvard Health Publications and a medical columnist for The Augusta Chronicle.

Awards

Dr. Mandawat was selected to the 2019 Class of 40 Under 40 University of Georgia Alumni and 40 Under 40 Rising Stars & Emerging Leaders in Cancer Award. He has also received the Farr Award, the Dr. Marvin Moser Award, and the Bechtel Award for his contributions in research.

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.